| Literature DB >> 30294234 |
Salina Saddick1, Mohamed Afifi2,3, Osama A Abu Zinada1.
Abstract
This study was carried out to determine the median lethal concentrations (LC50) of Zinc nanoparticles (ZnNPs) on Oreochromis niloticus and Tilapia zillii. The biochemical and molecular potential effects of ZnNPs (500 and 2000 μg L-1) on the antioxidant system in the brain tissue of O. niloticus and T. zillii were investigated. Four hundred fish were used for acute and sub-acute studies. ZnNP LC50 concentrations were investigated in O. niloticus and T. zillii. The effect of 500 and 2000 μg L-1 ZnNPs on brain antioxidants of O. niloticus and T. zillii was investigated. The result indicated that 69 h LC50 was 5.5 ± 0.6 and 5.6 ± 0.4 for O. nilotica and T. zillii, respectively. Fish exposed to 500 μg L-1 ZnNPs showed a significant increase in reduced glutathione (GSH), total glutathione (tGSH) levels, superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione-S-transferase (GST) activity and gene expression. On the contrary, malondialdehyde (MDA) levels significantly decreased. Meanwhile, fish exposed to 2000 μg L-1 ZnNPs showed a significant decrease of GSH, tGSH levels, SOD, CAT, GR, GPx and GST activity and gene expression. On the contrary, MDA levels significantly increased. It was concluded that, the 96 h LC50 of ZnNPs was 5.5 ± 0.6 and 5.6 ± 0.4 for O. nilotica and T. zillii, respectively. ZnNPs in exposure concentrations of 2000 μg/L induced a deleterious effect on the brain antioxidant system of O. nilotica and T. zillii. In contrast, ZnNPs in exposure concentrations of 500 μg L-1 produced an inductive effect on the brain antioxidant system of O. nilotica and T. zillii.Entities:
Keywords: Antioxidants; LC50; O. nilotica; T. zillii; ZnNPs
Year: 2015 PMID: 30294234 PMCID: PMC6169546 DOI: 10.1016/j.sjbs.2015.10.021
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 1319-562X Impact factor: 4.219
The actual ZnNP concentrations (mg L−1) in the exposed water.
| Concentrations | Time (h) | ||||
|---|---|---|---|---|---|
| Zero | 12 | 24 | |||
| M ± SD | M ± SD | % of change | M ± SD | % of change | |
| Control | nd | nd | nd | nd | nd |
| 500 μg L−1 | 500 ± 30 | 470 ± 23 | −6 | 450 ± 33 | −10 |
| 2000 μg L−1 | 2000 ± 125 | 1920 ± 104 | −4 | 1890 ± 106 | −5.5 |
nd = not detected.
Figure 1TEM photomicrograph of ZnNPs.
Lethal concentrations (mg/L) of ZnNPs on O. niloticus and T. zillii after 24, 48 and 96 h of exposure.
| Time (h) | Fish | Toxicity (mg L−1) | ||
|---|---|---|---|---|
| LC10 | LC50 | LC90 | ||
| 24 | 5.62 ± 0.9 | 7.48 ± 1 | 10.7 ± 1.3 | |
| 5.81 ± 1 | 7.6 ± 0.8 | 10.99 ± 1.2 | ||
| 48 | 4.89 ± 0.6 | 6.94 ± 0.9 | 8.98 ± 1.4 | |
| 5 ± 0.4 | 7 ± 1.1 | 9.2 ± 1.3 | ||
| 96 | 4 ± 0.7 | 5.5 ± 0.6 | 7.7 ± 1.2 | |
| 4.14 ± 0.5 | 5.6 ± 0.4 | 7.94 ± 1.1 | ||
Effect of ZnNPs on Zn, MDA, GSH and tGSH levels in the brain of O. niloticus.
| Group | Zn (μg g−1) | MDA (nmol g−1 wt.w) | GSH (μmol g−1 wt.w) | tGSH (μmol g−1 wt.w) |
|---|---|---|---|---|
| Control | 59.4 ± 5 | 1.8 ± 0.3 | 42.2 ± 3 | 67 ± 4 |
| 500 μg L−1 | 70.6 ± 6∗ | 1.06 ± 0.2∗∗ | 59 ± 3.4∗∗∗ | 78 ± 6∗ |
| 2000 μg L−1 | 99 ± 14∗∗∗,### | 6.1 ± 0.8∗∗∗,### | 22.4 ± 3.8∗∗∗,### | 45.8 ± 3.8∗∗∗,### |
wt.w: wet weight tissue. ∗: P < 0.05, ∗∗: P < 0.01, ∗∗∗: P < 0.001, compared to the control group; #: P < 0.05, ##: P < 0.01, ###: P < 0.001, comparing to 500 μg L−1 of the ZnNP exposed group.
Effect of ZnNPs on Zn, MDA, GSH and tGSH levels in the brain of T. Zillii.
| Group | Zn (μg g−1) | MDA (nmol g−1 wt.w) | GSH (μmol g−1 wt.w) | tGSH (μmol g−1 wt.w) |
|---|---|---|---|---|
| Control | 62.4 ± 5.3 | 1.6 ± 0.3 | 44.6 ± 4.2 | 69.2 ± 2.8 |
| 500 μg L−1 | 72.8 ± 8.2∗ | 0.8 ± 0.13∗∗∗ | 64.8 ± 6.7∗∗∗ | 80.8 ± 2.3∗ |
| 2000 μg L−1 | 102 ± 15∗∗∗,### | 5.2 ± 0.9∗∗∗,### | 17.8 ± 3.8∗∗∗,### | 39 ± 2.6∗∗∗,### |
wt.w: wet weight tissue. ∗: P < 0.05, ∗∗∗: P < 0.001, compared to the control group; ##: P < 0.01, ###: P < 0.001, comparing to 500 μg L−1 of the ZnNP exposed group.
Effect of ZnNPs on antioxidant enzymes activity in the brain of O. niloticus.
| Group | CAT μMH2O2 decomposed/g tissue | SOD ug/mgP | GST nmol/mg P/min | GR U/mgP | GPx (μU min−1 mg−1 P) |
|---|---|---|---|---|---|
| Control | 38.6 ± 3 | 20 ± 3 | 250 ± 19 | 18 ± 3 | 127 ± 15 |
| 500 μg L−1 | 40 ± 6.2 | 30 ± 2.1∗∗ | 308 ± 24∗∗ | 28.4 ± 3∗∗ | 182 ± 12∗∗∗ |
| 2000 μg L−1 | 26 ± 4∗∗,## | 12.2 ± 2∗,### | 96 ± 8∗∗∗,### | 9.8 ± 2∗,### | 71 ± 6∗∗∗,### |
∗: P < 0.05, ∗∗: P < 0.01, ∗∗∗: P < 0.001, compared to the control group; #: P < 0.05, ##: P < 0.01, ###: P < 0.001, comparing to 500 μg L−1 of the ZnNP exposed group.
Effect of ZnNPs on antioxidant enzyme activity in the brain of T. Zillii.
| Group | CAT μMH2O2 decomposed/g tissue | SOD ug/mgP | GST nmol/mg P/min | GR U/mgP | GPx (μU min−1 mg−1 P) |
|---|---|---|---|---|---|
| Control | 36.6 ± 3 | 18.4 ± 2.7 | 233 ± 16 | 17.4 ± 2.7 | 127.4 ± 28 |
| 500 μg L−1 | 43.6 ± 2.6∗∗ | 27.8 ± 2∗∗∗ | 304 ± 10∗∗∗ | 23 ± 2.4∗ | 180 ± 10∗∗ |
| 2000 μg L−1 | 13 ± 3∗∗∗,### | 9.4 ± 1∗∗∗,### | 102 ± 12∗∗∗,### | 6 ± 1∗∗∗,### | 81 ± 5∗∗∗,### |
wt.w: wet weight tissue. ∗: P < 0.05, ∗∗: P < 0.01, ∗∗∗: P < 0.001, compared to the control group; #: P < 0.05, ##: P < 0.01, ###: P < 0.001, comparing to 500 μg L−1 of the ZnNP exposed group.
Effect of ZnNPs on mRNA expression (relative expression to β-actin) of antioxidant genes in the brain of O. niloticus.
| Group | CAT | SOD | GST | GR | GPx |
|---|---|---|---|---|---|
| Control | 23.4 ± 2.9 | 7.4 ± 0.6 | 172 ± 11 | 1.4 ± 0.19 | 42 ± 8 |
| 500 μg L−1 | 34.2 ± 3.1∗∗ | 12.5 ± 1.8∗∗∗ | 221 ± 9∗∗∗ | 2.7 ± 0.2∗∗∗ | 52 ± 12∗∗ |
| 2000 μg L−1 | 12.6 ± 2∗∗∗,### | 4.8 ± 0.6∗∗∗,### | 115 ± 15∗∗∗,### | 0.76 ± 0.18∗∗,### | 29 ± 6∗∗,### |
∗: P < 0.05, ∗∗: P < 0.01, ∗∗∗: P < 0.001, compared to the control group; #: P < 0.05, ##: P < 0.01, ###: P < 0.001, comparing to 500 μg L−1 of the ZnNP exposed group.
Effect of ZnNPs on mRNA expression (relative expression to β-actin) of antioxidant genes in the brain of T. Zillii.
| Group | CAT | SOD | GST | GR | GPx |
|---|---|---|---|---|---|
| Control | 30 ± 2.5 | 7.8 ± 1 | 166 ± 8 | 1.66 ± 0.17 | 37.8 ± 10 |
| 500 μg L−1 | 34.8 ± 2.9∗ | 14.1 ± 3∗∗∗ | 208 ± 20∗∗∗ | 2.8 ± 0.16∗∗∗ | 47.4 ± 8∗ |
| 2000 μg L−1 | 13.2 ± 3∗∗∗,### | 4 ± 1∗∗∗,### | 97.4 ± 6∗∗∗,### | 0.58 ± 0.03∗∗∗,### | 26 ± 4∗∗,### |
∗: P < 0.05, ∗∗: P < 0.01, ∗∗∗: P < 0.001, compared to the control group; #: P < 0.05, ##: P < 0.01, ###: P < 0.001, comparing to 500 μg L−1 of the ZnNP exposed group.